Please login to the form below

Not currently logged in
Email:
Password:

PRAC

This page shows the latest PRAC news and features for those working in and with pharma, biotech and healthcare.

MHRA suspends new prescriptions of fibroid drug Esmya

MHRA suspends new prescriptions of fibroid drug Esmya

In December, the EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) started a review of the treatment for abnormal bleeding in women with uterine fibroids after four cases of serious liver injury -

Latest news

More from news
Approximately 5 fully matching, plus 25 partially matching documents found.

Latest Intelligence

  • Changes to pharmacovigilance legislation in Europe Changes to pharmacovigilance legislation in Europe

    If the same safety concerns apply to more than one medicinal product, the competent authority may, following consultation with the Pharmacovigilance Risk Assessment Advisory Committee (PRAC), encourage the performance of a ... Among others activities,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 2 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

GDPR and events. What does the pharma industry need to know?
...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....
The rise of vertical integration in the US payer landscape
Is it a solution to addressing the challenges of the value-based marketplace?...

Infographics